https://news.augustaheadlines.com/story/327930/acute-myelogenous-leukemia-emerging-therapies-clinical-nonclinical-studies-and-treatment-algorithm-key-companies-biosight-novartis-abbvie-astellas-maxinovel-pty-glycomimetics-and-others.html 2021-10-27T14:22:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/327841/iic-partners-elects-new-global-chair-and-board-directors.html 2021-10-27T14:18:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/327928/wet-agerelated-macular-degeneration-wet-amd-market-to-witness-upsurge-in-growth-during-the-forecast-period-2030-key-companies-allergan-bioeq-alkahest-regeneron-graybug-vision-and-others.html 2021-10-27T14:16:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/327926/triplenegative-breast-cancer-clinical-nonclinical-trials-analysis-emerging-pipeline-therapies-and-treatment-algorithm-key-companies-cytodyn-hibercell-roche-infinity-pharma-and-others.html 2021-10-27T14:10:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/327924/becker-muscular-dystrophy-treatment-market-to-witness-growth-by-2030-key-companies-ptc-therapeutics-italfarmaco-epirium-bio-edgewise-therapeutics-and-several-others.html 2021-10-27T14:06:31+00:00 daily 1.0 https://news.augustaheadlines.com/story/327922/adult-tcell-leukemialymphoma-market-to-exhibit-moderate-growth-rate-till-2030-key-companies-daiichi-sankyo-seagen-and-several-others.html 2021-10-27T14:02:01+00:00 daily 1.0 https://news.augustaheadlines.com/story/327920/respiratory-syncytial-virus-therapeutic-pipeline-analysis-clinical-trails-and-treatment-algorithm-key-companies-includes-medimmune-ark-biosciences-glaxosmithkline-medimmune-novavax-others.html 2021-10-27T13:56:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/327840/stafford-va-handyman-now-offers-a-seasonal-fall-discount-on-all-services-including-general-repairs-and-home-remodeling.html 2021-10-27T13:52:54+00:00 daily 1.0 https://news.augustaheadlines.com/story/327918/pompe-disease-clinical-nonclinical-studies-emerging-therapies-and-treatment-algorithm-key-companies-includes-sanofi-actus-amicus-roche-audentes-valerion-therapeutics-and-others.html 2021-10-27T13:52:24+00:00 daily 1.0 https://news.augustaheadlines.com/story/327917/acute-lung-injury-therapeutic-assessment-emerging-therapies-clinical-and-nonclinical-studies-key-companies-asklepion-viela-bio-roche-chimerix-astrazeneca-mereo-biopharma-and-others.html 2021-10-27T13:48:02+00:00 daily 1.0